{"id":6607,"date":"2004-12-01T13:24:00","date_gmt":"2004-12-01T13:24:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=6607"},"modified":"2022-01-27T14:24:24","modified_gmt":"2022-01-27T14:24:24","slug":"leucocytapheresis-for-ulcerative-colitis-2","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/leucocytapheresis-for-ulcerative-colitis-2\/","title":{"rendered":"Leucocytapheresis for ulcerative colitis"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>P.M. Irving, D.S. Rampton<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Digestive and Liver Disease 36 (2004) 799\u2013802<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>we discuss the theory behind using leucocytapheresis to treat IBD, its different forms, the way in which these remove leucocytes, and the indications, efficacy, safety, and possible future role of leucocytapheresis. <\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>if randomised controlled trials confirm its safety and efficacy in steroid-refractory colitis, it would be tempting to compare leucocytapheresis with cyclosporin rescue therapy in that it can be used on an out-patient basis and, unlike cyclosporin, is not yet reported to have serious side-effects. Furthermore, in patients refractory to aminosalicylates, leucocytapheresis could conceivably have a place as maintenance therapy. Azathioprine and 6-mercaptopurine are not always effective and have rare<br>but serious side-effects; leucocytapheresis, at least in theory, might be an attractive alternative.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15646424\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/15646424\/<\/a><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590-8658(04)00361-5\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590-8658(04)00361-5<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>P.M. Irving, D.S. Rampton Digestive and Liver Disease 36 (2004) 799\u2013802 we discuss the theory behind using leucocytapheresis to treat IBD, its different forms, the way in which these remove leucocytes, and the indications, efficacy, safety, and possible future role of leucocytapheresis. if randomised controlled trials confirm its safety and efficacy in steroid-refractory colitis, it [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[157,424,74,156,306],"class_list":["post-6607","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-efficacy","scientific_tags-gma","scientific_tags-leukocytapheresis","scientific_tags-safety","scientific_tags-ulcerative-colitis"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Leucocytapheresis for ulcerative colitis - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-for-ulcerative-colitis-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Leucocytapheresis for ulcerative colitis - Adacyte\" \/>\n<meta property=\"og:description\" content=\"P.M. Irving, D.S. Rampton Digestive and Liver Disease 36 (2004) 799\u2013802 we discuss the theory behind using leucocytapheresis to treat IBD, its different forms, the way in which these remove leucocytes, and the indications, efficacy, safety, and possible future role of leucocytapheresis. if randomised controlled trials confirm its safety and efficacy in steroid-refractory colitis, it [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-for-ulcerative-colitis-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-27T14:24:24+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-for-ulcerative-colitis-2\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-for-ulcerative-colitis-2\/\",\"name\":\"Leucocytapheresis for ulcerative colitis - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2004-12-01T13:24:00+00:00\",\"dateModified\":\"2022-01-27T14:24:24+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-for-ulcerative-colitis-2\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Leucocytapheresis for ulcerative colitis - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-for-ulcerative-colitis-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Leucocytapheresis for ulcerative colitis - Adacyte","og_description":"P.M. Irving, D.S. Rampton Digestive and Liver Disease 36 (2004) 799\u2013802 we discuss the theory behind using leucocytapheresis to treat IBD, its different forms, the way in which these remove leucocytes, and the indications, efficacy, safety, and possible future role of leucocytapheresis. if randomised controlled trials confirm its safety and efficacy in steroid-refractory colitis, it [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-for-ulcerative-colitis-2\/","og_site_name":"Adacyte","article_modified_time":"2022-01-27T14:24:24+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-for-ulcerative-colitis-2\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-for-ulcerative-colitis-2\/","name":"Leucocytapheresis for ulcerative colitis - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2004-12-01T13:24:00+00:00","dateModified":"2022-01-27T14:24:24+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/leucocytapheresis-for-ulcerative-colitis-2\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/6607","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=6607"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=6607"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}